Physician profile
Simona B Bartos
NPI 1174553846
$10,895.12
in general payments reported to CMS, 2019-2025
35 companies · $2,960 in 2025
The $2,960 reported for 2025 was more than what 92% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,241 · 2020: $744 · 2021: $608 · 2022: $311 · 2023: $1,666 · 2024: $2,366 · 2025: $2,960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,922 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,922.34 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,884.39 | 2019-2025 | Rinvoq, Skyrizi, Botox |
| Organogenesis INC. | $2,007.05 | 2023-2025 | Puraply, Via Matrix, Simplimax |
| Genzyme Corporation | $691.01 | 2019-2025 | |
| Pfizer INC. | $621.20 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $526.17 | 2019-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $477.84 | 2019-2025 | Winlevi, Absorica Ld |
| Mallinckrodt Hospital Products INC. | $429.51 | 2024-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $391.83 | 2019-2025 | |
| Janssen Biotech, INC. | $344.00 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Galderma Laboratories, L.P. | $318.99 | 2020-2025 | Nemluvio |
| Ucb, INC. | $287.97 | 2021-2025 | Bimzelx, Cimzia |
| Biofrontera INC. | $203.80 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Lilly USA, LLC | $181.25 | 2019-2025 | Ebglyss |
| Incyte Corporation | $147.40 | 2021-2025 | Opzelura |
| Genentech USA, INC. | $121.33 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $120.14 | 2020-2023 | Otezla |
| Janssen Scientific Affairs, LLC | $113.01 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $108.07 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $105.60 | 2021-2025 | |
| Leo Pharma INC. | $98.77 | 2020-2025 | Adbry, Anzupgo |
| Celgene Corporation | $98.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $97.56 | 2022-2025 | Sotyktu |
| Allergan, INC. | $97.33 | 2019 | |
| Arcutis Biotherapeutics, INC. | $65.14 | 2024-2025 | Zoryve |
| Botanix Sb INC | $59.29 | 2025 | Sofdra |
| Organon LLC | $53.54 | 2025 | Nexplanon |
| Verrica Pharmaceuticals INC. | $52.69 | 2024 | Ycanth |
| Journey Medical Corporation | $34.81 | 2023-2025 | |
| Dermavant Sciences, INC. | $29.61 | 2023 | Vtama |
| Vyne Pharmaceuticals INC. | $26.53 | 2020 | |
| Lnhc, INC | $23.90 | 2025 | Zelsuvmi |
| Smith+Nephew, INC. | $22.02 | 2022 | |
| Almirall LLC | $20.31 | 2025 | Klisyri |
| Sanofi-Aventis U.S. LLC | $17.56 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $17.46 | 2024 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simona Bartos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.